Influenza and Respiratory Syncytial Virus (RSV) Treatment Options (2023)
A new protocol for patients suffering from Influenza and Respiratory Syncytial Virus (RSV) has been developed in a collaboration led by Dr Paul Marik, Dr Pierre Kory and the Front Line COVID-19 Critical Care Alliance (FLCCC).
In adult patients, COVID-19 (Omicron variant), influenza, and RSV present with a similar constellation of symptoms and physical findings. It may therefore be difficult to distinguish between these infections (particularly COVID-19 and influenza) based on clinical presentation alone.
For advice on how to protect yourself against infection, see I-PREVENT: COVID Protection Protocol. For treatment of COVID-19, see I-CARE: Early COVID Treatment Protocol.